FDA plans new compounding pharmacy policy, agency head says

Reuters, 16 September 2017
Author: Nate Raymond
“The head of the U.S. Food and Drug Administration said on Friday the agency is working on a new policy that would encourage more compounding pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.”
Find article here.

‘His death still hurts’: the Pfizer anti-smoking drug ruled to have contributed to suicide

The Guardian, 15 September 2017
Author: Andrew McMillen
“When the retired Queensland schoolteacher Phoebe Morwood-Oldham started an online petition following her son’s suicide in April 2013, she could not have known that her insistence on asking hard questions of one of the world’s largest pharmaceutical companies would lead to an Australian-first finding by a state coroner.”
Find article here.

France to prosecute its drug regulator and Servier in scandal over diabetes drug

BMJ 2017; 358: j4231
Author: Owen Dyer
“France’s drug regulator and one of its leading drug companies, Servier, will stand trial as legal persons over the marketing of the antidiabetes and weight loss drug benfluorex (marketed in France as Mediator), which is believed to have killed between 500 and 2300 people before being pulled from the market in 2009.”
Find article here.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia

BMJ Open 2017; 7: e016701.
Authors: Fabbri A, Grundy Q, Mintzes B, et al
“To analyse patterns and characteristics of pharmaceutical industry sponsorship of events for Australian health professionals and to understand the implications of recent changes in transparency provisions that no longer require reporting of payments for food and beverages.”
Find article here.

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement

JAMA. 2017; 317(24): 2479-2480.
Authors: Sham Mailankody, Vinay Prasad
“This Viewpoint uses the recent instance of disease awareness promotion on a television soap opera to discuss questions about the role and regulation of novel forms of direct-to-consumer disease awareness marketing.”
Find article here.

A doctor prescribed so many painkillers, she’s been charged with murdering her patients, authorities say

Washington Post, 24 June 2017
Author: Cleve R. Wootson Jr.
“Law enforcement agents aren’t just going after drug dealers and Mexican cartels — they’re also targeting pharmaceutical companies and doctors, who they say are irresponsibly flooding the nation with potent painkillers, and holding them responsible for overdose deaths.”
Find article here.

AbbVie must pay $15 million in Depakote birth-defect trial: jury

Reuters, 9 June 2017
Author: Nate Raymond
“A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc’s (ABBV.N) bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product.”
Find article here.

 

Are Pharmaceutical Companies to Blame for the Opioid Epidemic?

The Atlantic, 2 June 2017
Author: Alana Semuels
“Who is responsible for this? Some attorneys general and advocates are now asking in court whether the pharmaceutical companies who marketed the drugs and downplayed their addictive nature can be held legally responsible for – and made to pay for the consequences of – the crisis.”
Find article here.